HK2 knockdown is associated with context-dependent inflammatory and angiogenesis-related transcriptional programmes in glioblastoma cells - Report - MDSpire

HK2 knockdown is associated with context-dependent inflammatory and angiogenesis-related transcriptional programmes in glioblastoma cells

  • By

  • Christopher Edwards

  • Taylor Richards

  • Hafid Omar Al-Hassi

  • Surya Prakash Shivakumar

  • Benjamin Small

  • Kate Butcher

  • Tracy Warr

  • Mark Morris

  • Timothy Dawson

  • Michael D. Jenkinson

  • Katherine Karakoula

  • June 16, 2026

  • 0 min

Share

Reduction of HK2 Expression Influences Inflammatory and Angiogenesis-Related Gene Expression Patterns in Glioblastoma Cells Depending on Context

Overview

This study investigates the effects of hexokinase 2 (HK2) knockdown on glycolytic activity and gene expression in glioblastoma cells. Findings indicate that HK2KD leads to reduced glycolytic activity and significant transcriptional changes related to inflammation and angiogenesis.

Background

Glioblastoma is the most common and aggressive brain tumor, with poor prognosis despite current treatment options. Targeting metabolic processes unique to glioblastoma, such as glycolysis, is being explored as a therapeutic strategy.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • HK2 knockdown (HK2KD) resulted in reduced glycolytic activity in glioblastoma models.
  • Extensive transcriptional remodelling was observed following HK2KD.
  • HK2KD influenced inflammatory, immune-associated, and angiogenesis-linked gene expression patterns.
  • Responses to HK2KD varied significantly between different glioblastoma models.

Clinical Implications

The findings indicate that targeting HK2 may influence inflammatory and angiogenic pathways in glioblastoma.

Conclusion

HK2KD is associated with significant changes in gene expression that may influence glioblastoma biology.

Related Resources & Content

  1. HMGA2 Serves as a Standalone Prognostic Marker and a Potential Treatment Target in IDH-Mutant Astrocytoma, Springer, 2025 -- https://link.springer.com/article/10.1007/s00701-025-06548-x
  2. Hexokinase 2 Upregulation is Associated with Glycolytic Reprogramming and Neuroinflammation in Hypoxic-Ischemic Brain Damage: A Therapeutic Target for Early Intervention, Frontiers in Immunology, 2026 -- https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1837728/full
  3. Effect of Micro-RNA on M2 Macrophages and Murine Glioblastoma, The ASCO Post, 2014 -- https://ascopost.com/issues/november-15-2014/effect-of-micro-rna-on-m2-macrophages-and-murine-glioblastoma.aspx
  4. Alterations in Chromatin Configuration Identify ARNT2 as a Key Component in a Tumorigenic Transcription Factor Profile Influencing Glioblastoma Cell Aggressiveness, Acta Neuropathologica, 2017 -- https://link.springer.com/article/10.1007/s00401-017-1783-x
  5. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine -- https://www.nejm.org/doi/full/10.1056/NEJMoa043330?utm_source=openai
  6. 2025 WHO CNS Classification Guidelines
  7. Angiogenesis in Glioblastoma—Treatment Approaches
  8. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma | New England Journal of Medicine

Original Source(s)

Related Content